SMTL ID : 5hi3.1

Binding site elucidation and structure guided design of macrocyclic IL-17A antagonists

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.15 Å

Oligo State

hetero-2-2-2-1-mer

Ligands

1 x 63O: N-(4-{2-[({1-[2-(dimethylamino)-2-oxoethyl]cyclopentyl}acetyl)amino]ethyl}phenyl)-2-fluoro-Nalpha-[(1-methyl-1H-pyrazol-5-yl)carbonyl]-L-phenylalaninamide(Non-covalent)

63O.1: 15 residues within 4Å: Chain A: P.63, E.95, I.96, L.97, K.114 Chain B: Y.62, P.63, V.65, I.66, E.95, I.96, L.97, V.98, L.99, L.112 14 PLIP interactions: 5 interactions with chain A, 9 interactions with chain B Hydrophobic interactions: A:L.97, A:L.97, A:K.114, B:Y.62, B:P.63, B:I.66, B:I.66, B:I.96, B:L.99, B:L.112 Hydrogen bonds: A:L.97, A:L.97, B:L.97, B:L.97

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Liu, S. et al., Binding site elucidation and structure guided design of macrocyclic IL-17A antagonists. Sci Rep (2016)

Release Date

2016-08-31

Peptides

Interleukin-17A: AB
CAT-2000 FAB heavy chain: CE
CAT-2000 FAB light chain: DG
synthetic IL-17A peptide inhibitor: F

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
C

E
H

D
D

G
L

F
I

Interleukin-17A

CAT-2000 FAB heavy chain

CAT-2000 FAB light chain

synthetic IL-17A peptide inhibitor

Related Entries With Identical Sequence